SuperworthIntegra Lifesciences shares outstanding IART
Diluted shares outstanding, averaged over each quarter, from 2009.
- Latest quarter, to Sep 30, 2026
- 78.6M
- On a year earlier
- +2.4%
- more shares
Integra Lifesciences had 78.6M diluted shares outstanding on average in Q3 FY26, the quarter to Sep 30, 2026.
That is 2.4% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 76.8M | +0% |
| FY2024 | 76.5M | −2% |
| FY2023 | 78M | −7% |
| FY2022 | 83.6M | −2% |
| FY2021 | 85.8M | +1% |
| FY2020 | 85M | −1% |
| FY2019 | 86.2M | −0% |
| FY2018 | 86.5M | +9% |
| FY2017 | 79.6M | −1% |
| FY2016 | 80.4M | +5% |
| FY2015 | 76.2M | +14% |
| FY2014 | 66.6M | +11% |
| FY2013 | 60.2M | +7% |
| FY2012 | 56.4M | −1% |
| FY2011 | 57.1M | −5% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q3 FY26 | 78.6M | +2% | |
| Q2 FY26 | 78.2M | +2% | |
| Q1 FY26 | 77M | +1% | |
| Q4 FY25 | 76.8M | +0% | |
| Q3 FY25 | 76.8M | +0% | |
| Q2 FY25 | 76.7M | −1% | |
| Q1 FY25 | 76.5M | −2% | |
| Q4 FY24 | 76.5M | −2% | |
| Q3 FY24 | 76.4M | −4% | |
| Q2 FY24 | 77.4M | −5% | |
| Q1 FY24 | 77.7M | −6% | |
| Q4 FY23 | 78M | −7% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Integra Lifesciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.